Morning Market Losers

Celladon Corp CLDN shares dipped 78.95 percent to $2.88 on the failed CUPID2 trial of MYDICAR in advanced heart failure. Akorn, Inc. AKRX shares declined 18.16 percent to $45.21 following the report of overstatement of revenue and downgrade. The company said it will make additional accounting restatements that will reduce previously reported revenue for the final three quarters of 2014. Piper Jaffray downgraded Akorn from Overweight to Neutral. American Science & Engineering, Inc. ASEI slipped 14.64 percent to $38.62. CRT Capital downgraded American Science from Fair Value to Sell. Silicom Ltd SILC shares declined 13.89 percent to $38.06. Silicom reported Q1 adjusted earnings of $0.52 per share on revenue of $18.8 million. Merge Healthcare Inc. MRGE shares dropped 12.09 percent to $5.31. Topeka Capital downgraded Merge Healthcare from Buy to Hold. Accuride Corporation ACW shares slipped 10.06 percent to $4.29. Accuride reported a Q1 loss of $0.01per share on revenue of $183.7 million. Applied Materials, Inc. AMAT shares fell 7.34 percent to $20.20 following the announcement of termination of business combination agreement with TOKYO ELECTRON LTD TOELY. Deutsche Bank AG (USA) DB shares slipped 4.23 percent to $32.81 on the announcement of business strategy. Deutsche Bank will spinoff Postbank branches in Germany via IPO. Marvell Technology Group Ltd. MRVL shares dropped 1.15 percent to $14.14. Marvell Technology said Q1 revenue will be below its earlier forecast.